Stopping RAS Inhibitors May Worsen Outcomes in CKD

FRIDAY, Jan. 15, 2021 -- The decision to stop renin-angiotensin system (RAS) inhibitor therapy in patients with advanced chronic kidney disease (CKD) should take into account both cardiovascular risk and the risk for kidney replacement therapy,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news